AnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer
August 05, 2022 16:45 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022
May 31, 2022 17:00 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, May 31, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio and New Investor Sign Equity Investment Totaling $15 Million
April 11, 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, April 11, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio’s Bio-Chip Subsidiary, Changwei System Technology Co., Ltd., Receives Independent Valuation and Approval from the Board to Explore Strategic Alternatives
March 03, 2022 07:00 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, March 03, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Files CDA Device for Breakthrough Medical Device Designation Request with the FDA
February 03, 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Feb. 03, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Class III Medical Device Passes Extensive NMPA Registration Tests and Will Start Clinical Trial in Q1, 2022
January 04, 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a US and China-based biotechnology company focused on early cancer...
Technical Paper on AnPac Bio Novel CDA Cancer Detection Technology Published by Peer-Reviewed International Medical Journal
December 10, 2021 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Dec. 10, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases
October 04, 2021 07:30 ET
|
Anpac Bio, USA
PHILADELPHIA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq:ANPC, “AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United...
AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3%
October 01, 2021 07:30 ET
|
Anpac Bio, USA
PHILADELPHIA, Oct. 01, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio’s USA Laboratory Receives Accreditation from the College of American Pathologists
August 30, 2021 07:30 ET
|
Anpac Bio, USA
PHILADELPHIA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States...